Institute for Health and Consumer Protection European Centre for the Validation of Alternative Methods (ECVAM)

Size: px
Start display at page:

Download "Institute for Health and Consumer Protection European Centre for the Validation of Alternative Methods (ECVAM)"

Transcription

1 EUROPEAN COMMISSION Curriculum Vitae 1. Name, Gender, Nationality Family Name Name Gender Nationality Basketter David Arthur Male British If you wish you can place a photograph of you here. 2. Overall Scientific Expertise Please specify in keywords (see section 3 of your application form). If you wish you may indicate how you acquired each specific expertise (e.g. through education, in your function as, through participation in ). CV Members of the ECVAM Scientific Advisory Committee (ESAC) Page 1 of 8

2 3. Professional Experience Professional Experience 1 (most recent) Occupation or Consultant Toxicologist position held Date (starting) Date (finishing) Current job Main activities Provision of a wide ranging toxicology consultancy service to companies around the world (chemical, pharmaceutical, household, cosmetic, both large and small). Specialised skills in allergy and irritancy as well as risk assessment. Main responsibilities Provision of toxicology review services; drafting of publications; negotiation with regulators, dermatologists; oral presentation; chairing of committees; participation in validation acitivities. Name of employing Address of employing (City, Country sufficient) Type of sector Professional Experience 2 DABMEB Consultancy Ltd 2 Normans Road, Sharnbrook, UK Specify (e.g. Academia, Industry, Governmental Body, Public institution, Civil Society Organisation etc.) Occupation or Senior Scientist position held Date (starting) Date (finishing) Main activities Safety evalution toxicologist with a wide range of responsibilities, particularly focused on allergy and irritancy, from in vitro method development, through in vivo testing to clinical studies. Some years spent being the toxicologist responsible for the safety of Unilever hair products globally. Main responsibilities Development of novel approaches to hazard identification and risk assessment. Safety assessment of the Unilever product portfolio (cosmetics, household products, chemicals). Liaison/influencing on safe levels of ingredients, acceptance of new test methods. For the latter part of my career, the key activity was to exercise global influence and to lead changes in regulatory toxicology. Name of employing Unilever Address of employing Colworth House, Sharnbrook, UK (City, Country sufficient) Type of sector Industry CV Members of the ECVAM Scientific Advisory Committee (ESAC) Page 2 of 8

3 Professional Experience 3 Occupation or Laboratory Scientist position held Date (starting) Date (finishing) Main activities Laboratory biochemistry Main responsibilities Fractionation of biological extracts Name of employing Weddel Pharmaceuticals Address of employing Old London Road, St Albans, UK (City, Country sufficient) Type of sector Industry 4. Educational Background Educational qualification 1 (most recent) Description of qualification achieved (e.g. Bachelor of science in tissue engineering) Principal subject (e.g. Animal Physiology) Fellowship of the Royal College of Pathology Toxicology (awarded by examination of publication record) Other subjects Date (starting) Date (finishing) Name of (incl. The Royal College of Pathologists city and country) awarding degree Title of degree awarded FRCPath Educational qualification 2 Description of qualification Doctor of Science achieved (e.g. Bachelor of science in tissue engineering) Principal subject (e.g. Animal The Toxicology of Contact Dermatitis Physiology) Other subjects Date (starting) Date (finishing) Name of (incl. University of London city and country) awarding degree Title of degree awarded DSc CV Members of the ECVAM Scientific Advisory Committee (ESAC) Page 3 of 8

4 Educational qualification 3 Description of qualification Bachelor of Science achieved (e.g. Bachelor of science in tissue engineering) Principal subject (e.g. Animal Physiology Physiology) Other subjects Biochemistry Date (starting) Date (finishing) Name of (incl. University of London city and country) awarding degree Title of degree awarded BSc 5. Fellowships, Awards, Membership in Learned Societies, Editorial Boards and Advisory Bodies 5.1 Fellowships Fellowship I Title of fellowship Fellowship of the Institute of Biology Description of fellowship Lifetime (type, maximal duration, prestige) Date (starting) Date (finishing) Funding/awarding Institute of Biology Address (city + country London, UK sufficient) Fellowship II Title of fellowship Fellowship of the British Toxicology Society Description of fellowship Lifetime (type, maximal duration, prestige) Date (starting) Date (finishing) Funding/awarding British Toxicology Society Address (city + country London, UK sufficient) CV Members of the ECVAM Scientific Advisory Committee (ESAC) Page 4 of 8

5 Fellowship III Title of fellowship Fellowship Academy of Toxicological Sciences Description of fellowship Lifetime (type, maximal duration, prestige) Date (starting) Date (finishing) Funding/awarding Academy of Toxicological Sciences Address (city + country USA sufficient) 5.2 Awards Award I Title of award Description of award (type, prestige etc.) Smith Kline Beecham Award for Animal Welfare The award is given to an individual judged to have made a significant contribution to animal welfare in toxicology. Date November 2000 Awarding Smith Kline Beecham Address (city + country sufficient) UK 5.3 Membership in learned societies & professional associations & editorial boards Society / Association / Editorial Board I Society / Association Description of society's / association's / board's activities 1. Contact Dermatitis 2. Cutaneous and Ocular Toxicology 1. Section Editor Toxicology for the journal Contact Dermatitis 2. Editorial board member CV Members of the ECVAM Scientific Advisory Committee (ESAC) Page 5 of 8

6 Membership from 2005 to (if currently member, please state 'current') present 5.4 Membership in advisory bodies / committees Advisory body / committee I Name of advisory body Description of the roles and responsibilities of the advisory body Sens-it-iv Scientific Advisory Board Chairman of the above board, advising on this Framework 6 EU research project. Membership from May 2008 to (if currently member, please state 'current') Current CV Members of the ECVAM Scientific Advisory Committee (ESAC) Page 6 of 8

7 6. Publications Nr. Citation 1 Basketter DA, Broekhuizen C, Fieldsend M, Kirkwood, Mascarenhas R, Maurer K, Pedersen C, Rodriguez C and Schiff H-E (2010) Defining occupational and consumer exposure limits for enzyme protein respiratory allergens under REACH. Toxicology, 268, Jirova D, Basketter D, Liebsch M, Bendova H, Keilova K, Marriott M and Kandarova H. (2010) Comparison of human skin irritation patch test data with in vitro skin irritation assays and animal data. Contact Dermatitis, 62, Coulter E M, Jenkinson C, Farrell J, Lavergne SN, Pease C K, White A, Aleksic A, Basketter DA, Williams D P, King C, Pirmohamded M, Park K, Naisbitt D J. (2010) Measurement of CD4+ and CD8+ cytokine secretion and gene expression changes in p-phenylenediamine allergic and tolerant individuals. J Invest Dermatol, 130, Kimber I, Basketter DA and Hartung T. (2010) The evolution of validation. Cutaneous and Ocular Toxicology, 29, Kern PS, Gerberick GF, Ryan CA, Kimber I, Aptula A and Basketter DA (2010) Historical local lymph node data for the evaluation of skin sensitization alternatives: a second compilation. Dermatitis, 21, Basketter DA (2010) Methyldibromo glutaronitrile, skin sensitisation and quantitative risk assessment. Cut. Ocul. Toxicol, 29, Basketter DA, Dearman RJ, Kimber I, Gerberick GF and Kimber I. (2009) The impact of LLNA group size on the identification and potency classification of skin sensitizers: a review of published data. Cutaneous and Ocular Toxicology, 28, Casati S, Aeby P, Kimber I, Maxwell G, Ovigne JM, Roggen E, Rovida C, Tosti L and Basketter DA (2009) Selection of chemicals for the development and evaluation of in vitro methods for skin sensitisation testing. Alternatives to Laboratory Animals, 37, McFadden JP, White JML, Basketter DA and Kimber I. (2009) Does hapten exposure predispose to atopic disease? The hapten-atopy hypothesis. Trends in Immunology, 30, Roberts DW and Basketter DA (2009). Reactivity assays, substances, samples and in vitro alternatives: why should we care? Contact Dermatitis. 61: Basketter DA (2009) The human repeated insult patch test in the 21st century: a commentary on ethics and validity. Cutaneous and Ocular Toxicology, 28, Basketter DA, McFadden JF, Gerberick GF, Cockshott A and Kimber I. (2009) Nothing is perfect, not even the local lymph node assay. A commentary and the implications for REACH. Contact Dermatitis, 60, White JML, White IR, Kimber I, Basketter DA, Buckley DA and McFadden JP (2009) Atopic dermatitis and allergic reactions to individual fragrance chemicals. Allergy, 64, Basketter DA and Kimber I (2009) Updating the skin sensitisation in vitro data assessment paradigm in Journal of Applied Toxicology,29, Kimber I and Basketter DA (2008) Thresholds, dose response relationships and dose metrics in allergic contact dermatitis. Letter. British Journal of Dermatology, 159, CV Members of the ECVAM Scientific Advisory Committee (ESAC) Page 7 of 8

8 16 Dearman RJ, Basketter DA, Maxwell G and Kimber I. (2008) Synergistic Effects of Chemical Insult and Toll-Like Receptor Ligands on Dendritic Cell Activation. Toxicology in Vitro, 22, McNamee PM, Basketter DA, Gerberick GF, Gilpin DA, Hall BM, Jowsey I and Robinson MK (2008) A review of critical factors in the conduct and interpretation of the human repeat insult patch test. Regulatory Toxicol and Pharmacol, 52, Kimber I, Dearman R J, Basketter D A, Ryan C A, Gerberick G F, Lalko J and Api A M. (2008) Dose metrics in the acquisition of skin sensitization: thresholds and importance of dose per unit area. Regulatory Toxicology and Pharmacology, 52, Api A M, Basketter D A, Cadby PA, Cano M-F, Ellis G, Gerberick G F, Griem P, McNamee P M, Ryan C A, Safford B. (2008) Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients. Regulatory Toxicology and Pharmacology, 52, Jirova D, Liebsch M, Basketter D, Kandarova H, Keilova K, Bendova H, Marriott M, Spiller E. (2008) comparison of human skin irritation and photo-irritation patch test data with cellular in vitro assays and animal in vivo data. AATEX 14, Basketter DA. (2008) Skin immunology and sensitisation. In Principles and Practice of Skin Toxicology. Eds Chilcott RP and Price S, Wiley, Chichester, pp Buckley DA, Basketter DA, Kan-King-Yu D, White IR, White JML and McFadden JP. (2008) Atopy and contact allergy to fragrance 1: Allergic reactions to the fragrance mix 1 (the Larssen mix). Contact Dermatitis, 59, Robinson S, Basketter D, Bussi R, Coenen J, Connolly P, Elvig-Jørgensen SG, Hermans H, Hoffmeister A, Lacerda A, Linge JP, Spielmann H, Török M, van der Valk J, Watson T. (2008) Dissemination strategies: how do they influence the uptake of the new Three Rs methods across laboratories and other boundaries? A report of a Workshop held by the European Partnership for Alternative Approaches to Animal Testing (EPAA) Working Group 3. Altern Lab Anim. 36: Basketter DA. (2008) Skin sensitisation: strategies for risk assessment and risk management. Brit J Dermatol, 159, Holden NJ, Bedford PA, McCarthy NE, Marks NE, Ind PW, Jowsey I, Basketter DA and Knight SC (2008) Dendritic cells from control but not atopic donors respond to contact and respiratory sensitiser treatment in vitro with differential cytokine production and altered stimulatory capacity. Clinical and Experimental Allergy, 38, Basketter D A. (2008) Information derived from sensitisation test methods: test sensitivity, false positives and false negatives. Regulatory Toxicology and Pharmacology, 50, Basketter DA, Cockshott A, Corsini E, Gerberick GF, Idehara K, Kimber I, van Loveren H, Takeyoshi M, Matheson J, Mehling A, Omori T, Rovida C, Sozy T, Stokes W and Casati S. (2008) An evaluation of performance standards and nonradioactive endpoints for the local lymph node assay. ATLA, 36, CV Members of the ECVAM Scientific Advisory Committee (ESAC) Page 8 of 8

HOW GOOD ARE VALIDATED METHODS TO PREDICT TOXICITY OF DIFFERENT TYPES OF SUBSTANCES AND PRODUCTS?

HOW GOOD ARE VALIDATED METHODS TO PREDICT TOXICITY OF DIFFERENT TYPES OF SUBSTANCES AND PRODUCTS? HOW GOOD ARE VALIDATED METHODS TO PREDICT TOXICITY OF DIFFERENT TYPES OF SUBSTANCES AND PRODUCTS? VERA ROGIERS Dept. Toxicology Vrije Universiteit Brussel Brussels, Belgium LAYOUT OF THE TALK CURRENT STATUS

More information

METHYLDIBROMO GLUTARONITRILE

METHYLDIBROMO GLUTARONITRILE OPINION OF THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS CONCERNING METHYLDIBROMO GLUTARONITRILE Colipa n P77 adopted by the SCCNFP during the 0 th plenary

More information

Application of the KeratinoSens Assay for Prediction of Dermal Sensitization Hazard for Botanical Cosmetic Ingredients

Application of the KeratinoSens Assay for Prediction of Dermal Sensitization Hazard for Botanical Cosmetic Ingredients Application of the KeratinoSens Assay for Prediction of Dermal Sensitization Hazard for Botanical Cosmetic Ingredients D. Gan 1, K. Norman 2, N. Barnes 2, H. Raabe 2, C. Gomez 1, and J. Harbell 1 1 Mary

More information

(This is a sample cover image for this issue. The actual cover is not yet available at this time.)

(This is a sample cover image for this issue. The actual cover is not yet available at this time.) (This is a sample cover image for this issue. The actual cover is not yet available at this time.) This article appeared in a journal published by Elsevier. The attached copy is furnished to the author

More information

Regulatory need for non-animal approaches for skin sensitisation hazard assessment. Janine Ezendam

Regulatory need for non-animal approaches for skin sensitisation hazard assessment. Janine Ezendam Regulatory need for non-animal approaches for skin sensitisation hazard assessment Janine Ezendam Janine.Ezendam@rivm.nl Contents 1. Background 2. Skin sensitisation AOP 3. OECD test guidelines 4. Defined

More information

An Example of Cross-Sector Dialogue at a Global Scale: The Case of Skin Sensitization

An Example of Cross-Sector Dialogue at a Global Scale: The Case of Skin Sensitization An Example of Cross-Sector Dialogue at a Global Scale: The Case of Skin Sensitization An in vitro Test Strategy for Assessment of the Skin Sensitization Hazard S.N. Kolle 1, C. Bauch 1, T. Ramirez 1, T.

More information

Potency Values from the Local Lymph Node Assay: Application to Classification, Labelling and Risk Assessment. Document No. 46

Potency Values from the Local Lymph Node Assay: Application to Classification, Labelling and Risk Assessment. Document No. 46 Potency Values from the Local Lymph Node Assay: Application to Classification, Labelling and Risk Assessment Document No. 46 Brussels, December 2008 ECETOC DOCUMENT NO. 46 Copyright ECETOC AISBL European

More information

Sherlock Holmes goesmolecular: Allergische Kontaktdermatitis von PatchTest zu Prohaptenen(I)

Sherlock Holmes goesmolecular: Allergische Kontaktdermatitis von PatchTest zu Prohaptenen(I) Sherlock Holmes goesmolecular: Allergische Kontaktdermatitis von PatchTest zu Prohaptenen(I) Hans F Merk Dept. of Dermatology & Allergology Univ.-Hospitals RWTH Aachen Sherlock Holmes goesmolecular: Allergische

More information

Identification of substances as SVHCs due to equivalent level of concern to CMRs (Article 57(f)) sensitisers as an example

Identification of substances as SVHCs due to equivalent level of concern to CMRs (Article 57(f)) sensitisers as an example 1 (20) Identification of substances as SVHCs due to equivalent level of concern to CMRs (Article 57(f)) sensitisers as an example In Article 57 of the REACH Regulation, criteria are laid down to identify

More information

CURRICULUM VITAE. NAME: David John BERRY YEAR OF BIRTH: 1945 NATIONALITY:

CURRICULUM VITAE. NAME: David John BERRY YEAR OF BIRTH: 1945 NATIONALITY: CURRICULUM VITAE NAME: David John BERRY YEAR OF BIRTH: 1945 NATIONALITY: British Telephone/FAX: +44(0)1342 324955 Mobile phone +44(0)7833 556460 HOME e-mail: LABORATORY ADDRESS: LABORATORY Phone: LABORATORY

More information

Selection of Chemicals for the Development and Evaluation of In Vitro Methods for Skin Sensitisation Testing

Selection of Chemicals for the Development and Evaluation of In Vitro Methods for Skin Sensitisation Testing ATLA 37, 305 312, 2009 305 Selection of Chemicals for the Development and Evaluation of In Vitro Methods for Skin Sensitisation Testing Silvia Casati, 1 Pierre Aeby, 2 Ian Kimber, 3 Gavin Maxwell, 4 Jean

More information

Sensitization testing in the frame of REACH: Any reliable in vitro alternatives in sight?

Sensitization testing in the frame of REACH: Any reliable in vitro alternatives in sight? Endpoint Skin Sensitization FEDERAL INSTITUTE FOR RISK ASSESSMENT Sensitization testing in the frame of REACH: Any reliable in vitro alternatives in sight? Andreas Luch & Matthias Peiser Department of

More information

PRESENTATION LAYOUT Introduction to chemical allergy. In vivo models. In vitro models

PRESENTATION LAYOUT Introduction to chemical allergy. In vivo models. In vitro models Sensibilizzazione cutanea: possibilità in vitro. Emanuela Corsini Laboratory of Toxicology, Department of Pharmacological Sciences, Faculty of Pharmacy, Università degli Studi di Milano, Milan, Italy PRESENTATION

More information

Validity of the QRA Methodology & Possibilities of Further Refinement

Validity of the QRA Methodology & Possibilities of Further Refinement Report on the IDEA Workshop on Validity of the QRA Methodology & Possibilities of Further Refinement March 11-13, 2014 Dolce La Hulpe Brussels Chaussée de Bruxelles, 135 B-1310 La Hulpe, Belgium 1. Background

More information

Chemical Respiratory Allergy: Clinical Information and How to Use it and Improve it

Chemical Respiratory Allergy: Clinical Information and How to Use it and Improve it WORKSHOP PROGRAMME Chemical Respiratory Allergy: Clinical Information and How to Use it and Improve it 27 th and 28 th October 2016 NH Nacional Hotel Madrid, Spain Organised by: European Centre for Ecotoxicology

More information

Self-Diagnosed Sensitive Skin in Women with Clinically Diagnosed Atopic Dermatitis

Self-Diagnosed Sensitive Skin in Women with Clinically Diagnosed Atopic Dermatitis ORIGINAL RESEARCH SPECIAL ISSUE Self-Diagnosed Sensitive Skin in Women with Clinically Diagnosed Atopic Dermatitis Miranda A. Farage 1, Philip Bowtell 2, and Alexandra Katsarou 3 1 Feminine Clinical Sciences,

More information

SCIENTIFIC COMMITTEE ON CONSUMER PRODUCTS SCCP. Memorandum Classification and categorization of skin sensitisers and grading of test reactions

SCIENTIFIC COMMITTEE ON CONSUMER PRODUCTS SCCP. Memorandum Classification and categorization of skin sensitisers and grading of test reactions EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCIENTIFIC COMMITTEE ON CONSUMER PRODUCTS SCCP Memorandum Classification

More information

Feasibility of a study to assess the effectiveness of QRA

Feasibility of a study to assess the effectiveness of QRA Rapporteur s Progress Report on the 2 nd IDEA Working Group meeting on the Feasibility of a study to assess the effectiveness of QRA February 15 th, 2017 from 9:00 to 16:00 Martin s Klooster Hotel Onze

More information

Skin Sensitization MoA/AOP pathway elucidation: Applying the Skin Sensitization AOP to Risk Assessment

Skin Sensitization MoA/AOP pathway elucidation: Applying the Skin Sensitization AOP to Risk Assessment Skin Sensitization MoA/AOP pathway elucidation: Applying the Skin Sensitization AOP to Risk Assessment Gavin Maxwell, Unilever (gavin.maxwell@unilever.com) Maja Aleksic, Richard Cubberley, Michael Davies,

More information

Potency classification of skin sensitizers (EC WG on Sensitization)

Potency classification of skin sensitizers (EC WG on Sensitization) Potency classification of skin sensitizers (EC WG on Sensitization) Carola Lidén, Professor, MD 1 Occupational and environmental dermatology Clinical, experimental and epidemiological research Risk assessment

More information

Comparison of human skin irritation patch test data with in vitro skin irritation assays and animal data

Comparison of human skin irritation patch test data with in vitro skin irritation assays and animal data Contact Dermatitis 2010: 62: 109 116 Printed in Singapore. All rights reserved 2010 John Wiley & Sons A/S CONTACT DERMATITIS Comparison of human skin irritation patch test data with in vitro skin irritation

More information

FROM PATHWAYS TO PEOPLE: APPLYING THE SKIN SENSITISATION AOP TO RISK ASSESSMENT

FROM PATHWAYS TO PEOPLE: APPLYING THE SKIN SENSITISATION AOP TO RISK ASSESSMENT FROM PATHWAYS TO PEOPLE: APPLYING THE SKIN SENSITISATION AOP TO RISK ASSESSMENT GAVIN MAXWELL, CATHERINE CLAPP, RICHARD CUBBERLEY, SERAYA DHADRA, NIKKI GELLATLY, STEPHEN GLAVIN, SARAH HADFIELD, SANDRINE

More information

Technical Report No. 78. Skin Sensitisation Testing: Methodological Considerations

Technical Report No. 78. Skin Sensitisation Testing: Methodological Considerations ECETOC Technical Report No. 78 Skin Sensitisation Testing: Methodological Considerations European Centre for Ecotoxicology Avenue E. Van Nieuwenhuyse 4, (Bte 6) and Toxicology of Chemicals B-1160 Brussels,

More information

IL-8 Luciferase (IL-8 Luc) Assay. Report of the Peer Review Panel

IL-8 Luciferase (IL-8 Luc) Assay. Report of the Peer Review Panel IL-8 Luciferase (IL-8 Luc) Assay Report of the Peer Review Panel on a JaCVAM co-ordinated study programme addressing the validation status of the IL-8 Luc assay for the prospective identification of skin

More information

Assessing the sensitization/irritation properties of micro organisms. Gregorio Loprieno Prevention Medicine Local Health Authority 2 Lucca (Italy)

Assessing the sensitization/irritation properties of micro organisms. Gregorio Loprieno Prevention Medicine Local Health Authority 2 Lucca (Italy) Assessing the sensitization/irritation properties of micro organisms Gregorio Loprieno Prevention Medicine Local Health Authority 2 Lucca (Italy) 1 Italian National Expert Group (GNE) Dir. 91/414 Prof.

More information

Why me? 35 years in toxicology, incl. 28 with Unilever. Director of DABMEB Consultancy Ltd for 6 years

Why me? 35 years in toxicology, incl. 28 with Unilever. Director of DABMEB Consultancy Ltd for 6 years Why me? 35 years in toxicology, incl. 28 with Unilever Director of DABMEB Consultancy Ltd for 6 years Long experience in allergy and irritation testing, risk assessment and regulation Past president of

More information

A Bayes Linear Approach to Weight-of-Evidence Risk Assessment for Skin Allergy

A Bayes Linear Approach to Weight-of-Evidence Risk Assessment for Skin Allergy Bayesian Analysis (2013) 8, Number 1, pp. 169 186 A Bayes Linear Approach to Weight-of-Evidence Risk Assessment for Skin Allergy John Paul Gosling, Andy Hart :, Helen Owen ;, Michael Davies, Jin Li, and

More information

BOHRF BOHRF BOHRF BOHRF

BOHRF BOHRF BOHRF BOHRF Occupational Contact Dermatitis and Urticaria A Guide for General Practitioners and Practice Nurses March 2010 British Occupational Health Research Foundat ion This leaflet summarises the key evidence

More information

The COLIPA strategy for the development of in vitro alternatives: Skin sensitisation

The COLIPA strategy for the development of in vitro alternatives: Skin sensitisation AATEX 14, Special Issue, 375-379 Proc. 6th World Congress on Alternatives & Animal Use in the Life Sciences August 21-25, 2007, Tokyo, Japan The COLIPA strategy for the development of in vitro alternatives:

More information

Chemical Respiratory Allergy: Clinical Information and How To Use It and Improve It. Madrid, 27-28th October Workshop Report No.

Chemical Respiratory Allergy: Clinical Information and How To Use It and Improve It. Madrid, 27-28th October Workshop Report No. Chemical Respiratory Allergy: Clinical Information and How To Use It and Improve It Madrid, 27-28th October 2016 Workshop Report No. 33 EUROPEAN CENTRE FOR ECOTOXICOLOGY AND TOXICOLOGY OF CHEMICALS Chemical

More information

Dermal Sensitization Quantitative Risk Assessment (QRA) For Fragrance Ingredients

Dermal Sensitization Quantitative Risk Assessment (QRA) For Fragrance Ingredients Dermal Sensitization Quantitative Risk Assessment (QRA) For Fragrance Ingredients Anne Marie Api, PhD Vice President, Human Health Sciences Research Institute for Fragrance Materials, Inc. Tel.: 201.689.8089

More information

FORUM Skin Sensitization Testing in Potency and Risk Assessment

FORUM Skin Sensitization Testing in Potency and Risk Assessment TOXICOLOGICAL SCIENCES 59, 198 208 (2001) Copyright 2001 by the Society of Toxicology FORUM Skin Sensitization Testing in Potency and Risk Assessment I. Kimber, a,1 D. A. Basketter, b K. Berthold, c M.

More information

LRI Workshop: Applicability of Skin Sensitisation Testing Methods for Regulatory Purposes. Brussels; 2-3 February 2010

LRI Workshop: Applicability of Skin Sensitisation Testing Methods for Regulatory Purposes. Brussels; 2-3 February 2010 LRI Workshop: Applicability of Skin Sensitisation Testing Methods for Regulatory Purposes. Brussels; 2-3 February 2010 Workshop Steering Committee: Juan-Carlos Carrillo 1, Cedric Delveaux 2, Dorothea Eigler

More information

Identification of the causes of an allergic reaction to a fragranced consumer product #

Identification of the causes of an allergic reaction to a fragranced consumer product # Recommended Practice Received 30 March 2010; Revised 2 June 2010; Accepted 20 July 2010; Published online in Wiley Online Library (wileyonlinelibrary.com) DOI 10.1002/ffj.2021 Identification of the causes

More information

OECD GUIDELINE FOR THE TESTING OF CHEMICALS

OECD GUIDELINE FOR THE TESTING OF CHEMICALS 1 2 3 OECD GUIDELINE FOR THE TESTING OF CHEMICALS DRAFT PROPOSAL FOR A NEW TEST GUIDELINE Skin Sensitisation: Local Lymph Node Assay: BrdU-ELISA 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

More information

IPCS Project on the Harmonization of Approaches to the Assessment of Risk from Exposure to Chemicals

IPCS Project on the Harmonization of Approaches to the Assessment of Risk from Exposure to Chemicals IPCS Project on the Harmonization of Approaches to the Assessment of Risk from Exposure to Chemicals GENERAL CONCLUSIONS AND RECOMMENDATIONS 1 OF AN IPCS INTERNATIONAL WORKSHOP ON SKIN SENSITIZATION IN

More information

Evaluation of Sex Sensitivity in Local Lymph Node Assay Using Acephate and α- Hexylcinnamaldehyde

Evaluation of Sex Sensitivity in Local Lymph Node Assay Using Acephate and α- Hexylcinnamaldehyde IOSR Journal of Environmental Science, Toxicology and Food Technology (IOSR-JESTFT) e-issn: 2319-2402,p- ISSN: 2319-2399.Volume 8, Issue 6 Ver. III (Jun. 2014), PP 31-37 Evaluation of Sex Sensitivity in

More information

Multivariate Models for Skin Sensitization Hazard and Potency

Multivariate Models for Skin Sensitization Hazard and Potency Multivariate Models for Skin Sensitization Hazard and Potency Judy Strickland Integrated Laboratory Systems, Inc. Contractor Supporting the NTP Interagency Center for the Evaluation of Alternative Toxicological

More information

Institute for Health and Consumer Protection In vitro methods Unit European Centre for the Validation of Alternative Methods (ECVAM)

Institute for Health and Consumer Protection In vitro methods Unit European Centre for the Validation of Alternative Methods (ECVAM) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 STATEMENT ON THE PERFORMANCE UNDER UN GHS OF THREE IN-VITRO ASSAYS FOR SKIN IRRITATION

More information

Application of a systems biology approach for skin allergy risk assessment

Application of a systems biology approach for skin allergy risk assessment AATEX 14, Special Issue, 381-388 Proc. 6th World Congress on Alternatives & Animal Use in the Life Sciences August 21-25, 2007, Tokyo, Japan Application of a systems biology approach for skin allergy risk

More information

Memorandum on use of Human Data in risk assessment of skin sensitisation

Memorandum on use of Human Data in risk assessment of skin sensitisation Scientific Committee on Consumer Safety SCCS Memorandum on use of Human Data in risk assessment of skin sensitisation The SCCS adopted this memorandum at its 12th Plenary meeting on 15 December 2015 1

More information

Comments on the Proposal for Harmonized Classification and Labelling of Linalool for skin sensitization sub-category 1A

Comments on the Proposal for Harmonized Classification and Labelling of Linalool for skin sensitization sub-category 1A Comments on the Proposal for Harmonized Classification and Labelling of Linalool for skin sensitization sub-category 1A Linalool EC No: 201-134-4 CAS No: 78-70-6 Givaudan International SA 5 chemin de la

More information

Methyldibromoglutaronitrile

Methyldibromoglutaronitrile EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCIENTIFIC COMMITTEE ON CONSUMER PRODUCTS SCCP Opinion on Methyldibromoglutaronitrile

More information

Challenges of 21 st Century Toxicology

Challenges of 21 st Century Toxicology Challenges of 21 st Century Toxicology Toxicology and Mathematical Modelling 2 nd March 2012 Cameron MacKay Unilever Safety and Environmental Assurance Centre What is Unilever? Consumer goods company Unilever

More information

Contact Sensitisation: Classification According to Potency A Commentary. Document No. 43

Contact Sensitisation: Classification According to Potency A Commentary. Document No. 43 Contact Sensitisation: Classification According to Potency A Commentary Document No. 43 Brussels, July 2003 A Commentary ECETOC Document No. 43 Copyright - ECETOC European Centre for Ecotoxicology and

More information

CASE STUDY PRESENTATION: A QUANTITATIVE AOP FOR SKIN SENSITISATION RISK ASSESSMENT

CASE STUDY PRESENTATION: A QUANTITATIVE AOP FOR SKIN SENSITISATION RISK ASSESSMENT CASE STUDY PRESENTATION: A QUANTITATIVE AOP FOR SKIN SENSITISATION RISK ASSESSMENT GAVIN MAXWELL, CATHERINE CLAPP, RICHARD CUBBERLEY, SERAYA DHADRA, NIKKI GELLATLY, STEPHEN GLAVIN, SARAH HADFIELD, SANDRINE

More information

Toxicology Letters 192 (2010) Contents lists available at ScienceDirect. Toxicology Letters. journal homepage:

Toxicology Letters 192 (2010) Contents lists available at ScienceDirect. Toxicology Letters. journal homepage: Toxicology Letters 192 (2010) 229 237 Contents lists available at ScienceDirect Toxicology Letters journal homepage: www.elsevier.com/locate/toxlet Comparison of flow cytometry and immunohistochemistry

More information

CURRICULUM VITAE. AFFILIATION: Ankara University, Faculty of Pharmacy, Department of Toxicology, Ankara,Turkey

CURRICULUM VITAE. AFFILIATION: Ankara University, Faculty of Pharmacy, Department of Toxicology, Ankara,Turkey CURRICULUM VITAE NAME: Ozge Ulker DATE OF BIRTH: 13.06.1979 CURRENT POSITION: Research Assistant AFFILIATION: Ankara University, Faculty of Pharmacy, Department of Toxicology, Ankara,Turkey EDUCATION:

More information

Opinion on QRA SCCP 24 June 2008

Opinion on QRA SCCP 24 June 2008 Opinion on QRA SCCP 24 June 2008 Jeanne Duus Johansen National Allergy Research Centre Department of Dermato-allergology Copenhagen University Hospital Gentofte Denmark Background Many commonly used fragrance

More information

skin corrosion factsheet animal test non-animal test give the animals 5 factsheet 1 / skin corrosion

skin corrosion factsheet animal test non-animal test give the animals 5 factsheet 1 / skin corrosion 1 skin corrosion Corrosive agents are chemicals that cause irreversible damage and destruction of the skin, often burning through several layers of tissue. Corrosive reactions are typified by ulcers, bleeding,

More information

Dermal Toxicology Specialty Section

Dermal Toxicology Specialty Section Dermal Toxicology Specialty Section Executive Council President George L. DeGeorge, PhD, DABT MB Research Laboratories degeorge@mbresearch.com President-Elect William G. Reifenrath Stratacor, Inc. wgr@stratacor-inc.com

More information

Background on skin sensitization hazard identification: Aspects in the development of «in-vitro based alternatives for sensitization testing»

Background on skin sensitization hazard identification: Aspects in the development of «in-vitro based alternatives for sensitization testing» Background on skin sensitization hazard identification: FEDERAL INSTITUTE FOR RISK ASSESSMENT Aspects in the development of «in-vitro based alternatives for sensitization testing» Dr. Matthias Peiser Department

More information

Guidance on use of alternative methods for testing in the safety assessment of cosmetics and quasi-drug

Guidance on use of alternative methods for testing in the safety assessment of cosmetics and quasi-drug Asian Congress 2016, Nov. 15, 2016, Karatsu, Saga, Japan Guidance on use of alternative methods for testing in the safety assessment of cosmetics and quasi-drug Hajime Kojima, NIHS, et al. 1 Table 1. Test

More information

Annex II: Lymph node assay (LLNA) data on 59 fragrance substances, based on a summary report submitted by the Research Institute for Fragrance

Annex II: Lymph node assay (LLNA) data on 59 fragrance substances, based on a summary report submitted by the Research Institute for Fragrance Annex II: Lymph node assay (LLNA) data on 59 fragrance s, based on a summary report submitted by Research Institute for Fragrance Materials, Inc. (RIFM, 2009) 1 INCI name (or name) Allyl phenoxyacetate

More information

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL. Held on 20 September 2005 in Brussels MINUTES

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL. Held on 20 September 2005 in Brussels MINUTES EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C Public Health and Risk Assessment C7 Risk assessment Scientific Committee on Consumer Products SCIENTIFIC COMMITTEE ON

More information

In Vitro Lecture and Luncheon. Sponsored by the Colgate Palmolive Company

In Vitro Lecture and Luncheon. Sponsored by the Colgate Palmolive Company In Vitro Lecture and Luncheon Sponsored by the Colgate Palmolive Company More Than Skin Deep: When Alternative Approaches Outperform Animal Tests 2018 In Vitro Lecture Nicole Kleinstreuer Speaker Schedule

More information

OECD GUIDELINE FOR THE TESTING OF CHEMICALS

OECD GUIDELINE FOR THE TESTING OF CHEMICALS 1 2 3 OECD GUIDELINE FOR THE TESTING OF CHEMICALS DRAFT PROPOSAL FOR A NEW TEST GUIDELINE Skin Sensitisation: Local Lymph Node Assay: BrdU-ELISA 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

More information

RESEARCHER DEVELOPMENT DAYS 2016/2017. Wednesday 30 November 2016

RESEARCHER DEVELOPMENT DAYS 2016/2017. Wednesday 30 November 2016 RESEARCHER DEVELOPMENT DAYS 2016/2017 Wednesday 30 November 2016 Seminar Room 02/6008, 2 nd Floor UCL Centre for Nephrology Royal Free Hospital Rowland Hill Street London, NW3 2PF DELEGATE PACK Kidney

More information

University of Dundee. DOI: /bjd Publication date: Document Version Peer reviewed version

University of Dundee. DOI: /bjd Publication date: Document Version Peer reviewed version University of Dundee Has the epidemic of allergic contact dermatitis due to Methylisothiazolinone reached its peak? Venables, Z. C.; Bourke, J. F.; Buckley, D. A.; Campbell, F.; Chowdhury, M. M. U.; Abdul-

More information

Regulatory Toxicologic Pathology; Module III:

Regulatory Toxicologic Pathology; Module III: Modular Courses in Regulatory Toxicologic Pathology at Sree Chitra Tirunal Institute for Medical Sciences and Technology Trivandrum 695012, India Course announcement Regulatory Toxicologic Pathology; Module

More information

Science for All, All for Science Scientific Achievements of ILSI Europe

Science for All, All for Science Scientific Achievements of ILSI Europe Science for All, All for Science Scientific Achievements of ILSI Europe ILSI Europe 2013 Annual Symposium 26-27 March 2013, Brussels, Belgium Prof. Diána Bánati Executive and Scientific Director, ILSI

More information

In vitro models for assessment of the respiratory sensitization potential of compounds.

In vitro models for assessment of the respiratory sensitization potential of compounds. In vitro models for assessment of the respiratory sensitization potential of compounds. 1 Investment driving Animal-free Testing Setting the scene 2 What we know about skin sensitization induction in a

More information

Prof. Jean-Pierre Lepoittevin University of Strasbourg, France SCCS WG on methodology Luxemburg, July 1st 2015

Prof. Jean-Pierre Lepoittevin University of Strasbourg, France SCCS WG on methodology Luxemburg, July 1st 2015 Potency classification of skin sensitizers: development and use of in vitro methods Prof. Jean-Pierre Lepoittevin University of Strasbourg, France SCCS WG on methodology Luxemburg, July 1st 2015 Research

More information

METHODOLOGIES FOR INTERMITTENT AND SHORT-TERM EXPOSURE TO CARCINOGENS SUBCOMMITTEE

METHODOLOGIES FOR INTERMITTENT AND SHORT-TERM EXPOSURE TO CARCINOGENS SUBCOMMITTEE METHODOLOGIES FOR INTERMITTENT AND SHORT-TERM EXPOSURE TO CARCINOGENS SUBCOMMITTEE Mission The mission of the MISTEC Subcommittee is to develop methodologies for establishing appropriate dose-metrics to

More information

RESEARCHERS FROM A*STAR AND NUS IMPLICATE HOUSE DUST MITES AS THE MAIN CAUSE OF RESPIRATORY ALLERGIES IN SINGAPORE

RESEARCHERS FROM A*STAR AND NUS IMPLICATE HOUSE DUST MITES AS THE MAIN CAUSE OF RESPIRATORY ALLERGIES IN SINGAPORE MEDIA RELEASE 07 Feb 2014 RESEARCHERS FROM A*STAR AND NUS IMPLICATE HOUSE DUST MITES AS THE MAIN CAUSE OF RESPIRATORY ALLERGIES IN SINGAPORE Study findings provide a basis for developing effective allergy

More information

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL. Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCCP

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL. Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCCP SCCP0084704 EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCIENTIFIC COMMITTEE ON CONSUMER PRODUCTS SCCP Opinion

More information

RESEARCHER DEVELOPMENT DAYS 2016/2017. Wednesday 30 November 2016

RESEARCHER DEVELOPMENT DAYS 2016/2017. Wednesday 30 November 2016 RESEARCHER DEVELOPMENT DAYS 2016/2017 Wednesday 30 November 2016 Seminar Room 02/6008, 2 nd Floor UCL Centre for Nephrology Royal Free Hospital Rowland Hill Street London, NW3 2PF DELEGATE PACK Kidney

More information

Chemical atopy COD. Contact Dermatitis. Pailin Puangpet 1,2, Joey Lai-Cheong 3 and John P. McFadden 1

Chemical atopy COD. Contact Dermatitis. Pailin Puangpet 1,2, Joey Lai-Cheong 3 and John P. McFadden 1 Contact Dermatitis Original Article COD Contact Dermatitis Chemical atopy Pailin Puangpet 1,2, Joey Lai-Cheong 3 and John P. McFadden 1 1 Department of Cutaneous Allergy, St. John s Institute of Dermatology,

More information

Contact Sensitisation: Classification According to Potency. Technical Report No. 87

Contact Sensitisation: Classification According to Potency. Technical Report No. 87 Contact Sensitisation: Classification According to Potency Technical Report No. 87 ISSN-0773-8072-87 Brussels, April 2003 ECETOC Technical Report 87 Copyright - ECETOC European Centre for Ecotoxicology

More information

Sens-it-iv Proof-of-concept studies

Sens-it-iv Proof-of-concept studies Sens-it-iv Proof-of-concept studies Erwin L. Roggen 1 The Sens-it-iv toolbox (2011) Haptenation Protein binding Epidermal inflammation Keratinocytes NCTC2544 test Human reconstituted skin Lung EC Precision

More information

Dermal Technology Laboratory Ltd

Dermal Technology Laboratory Ltd Dermal Technology Laboratory Ltd EFSA Guidance on Dermal Absorption (2017) : Industry View j Prof. Jon Heylings Chairman, DTL Ltd Professor of Toxicology Keele University, UK History DTL is an independent

More information

We are currently recruiting new members to advisory groups for the following research programmes:

We are currently recruiting new members to advisory groups for the following research programmes: Information for applicants to join NIHR as an advisory group member: HTA Programme Topic Identification, Development and Evaluation (TIDE) panel Chairs 1. Background information The goal of the National

More information

Important issues in immunotoxicity testing of chemicals

Important issues in immunotoxicity testing of chemicals Important issues in immunotoxicity testing of chemicals Pr Marc Pallardy, Toxicologie and INSERM UMR-S 749, Faculté de Pharmacie, Châtenay-Malabry, France Innate immune response: non antigen specific Physical

More information

Examples of Selection Criteria for the EAMA

Examples of Selection Criteria for the EAMA Examples of Selection Criteria for the EAMA Category 1 Category 2 Category 3 MD members of the staff with a PhD degree and experience in clinical work, research and education of students of departments

More information

Report /2009 J. Ezendam et al. Immune effects of inhalation exposure to fragrance allergens

Report /2009 J. Ezendam et al. Immune effects of inhalation exposure to fragrance allergens Report 340301003/2009 J. Ezendam et al. Immune effects of inhalation exposure to fragrance allergens RIVM Letter Report 340301003/2009 Immune effects of inhalation exposure to fragrance allergens J. Ezendam,

More information

SAFETY DATA SHEET =44 (0) OFFICE HOURS ONLY

SAFETY DATA SHEET =44 (0) OFFICE HOURS ONLY Page: 1 Compilation date: 16/02/2016 Revision date: 21/02/2018 Revision No: 3 Section 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name: Product

More information

BSc (Hons) Medical Physiology and Diagnostics

BSc (Hons) Medical Physiology and Diagnostics BSc (Hons) Medical Physiology and Diagnostics Wolverhampton School of Sciences Ucas code: B122 Location Study mode Duration Start date Wolverhampton City Campus Full-time 3 year(s) 23/09/2019 Wolverhampton

More information

ESMO FELLOWSHIP PROGRAMME & LEADERS GENERATION PROGRAMME

ESMO FELLOWSHIP PROGRAMME & LEADERS GENERATION PROGRAMME ESMO FELLOWSHIP PROGRAMME & LEADERS GENERATION PROGRAMME Christoph Zielinski Chair of the ESMO Fellowship & Award Committee esmo.org ESMO FELLOWSHIP PROGRAMME Exclusive to ESMO members under 40 years old

More information

Diversity Clinical Research Workshop Invited Faculty

Diversity Clinical Research Workshop Invited Faculty Diversity Clinical Research Workshop Invited Faculty Alex A. Adjei, MD, PhD, FACP Professor and Chair, Department of Medicine Senior Vice President of Clinical Research The Katherine Anne Gioia Chair in

More information

Lisa F. Pratt 1, Matthew Troese 1, Dirk Weisensee 2, Oliver Engelking 2, Horst W. Fuchs 2 and George DeGeorge 1

Lisa F. Pratt 1, Matthew Troese 1, Dirk Weisensee 2, Oliver Engelking 2, Horst W. Fuchs 2 and George DeGeorge 1 Potency Ranking of Dermal Sensitizing Chemicals Using the IVSA and epics Skin Tissues Lisa F. Pratt, Matthew Troese, Dirk Weisensee 2, Oliver Engelking 2, Horst W. Fuchs 2 and George DeGeorge MB Research

More information

Review of skin irritation/corrosion Hazards on the basis of human data: A regulatory perspective

Review of skin irritation/corrosion Hazards on the basis of human data: A regulatory perspective Interdiscip Toxicol. 2012; Vol. 5(2): 98 104. doi: 10.2478/v10102-012-0017-2 Published online in: www.intertox.sav.sk & www.versita.com/science/medicine/it/ Copyright 2012 SETOX & IEPT, SASc. This is an

More information

OCCUPATIONAL CONTACT DERMATITIS IN A TERTIARY CARE CENTRE EPIDEMIOLOGY, CLINICAL PROFILE AND PATCH TEST EVALUATION

OCCUPATIONAL CONTACT DERMATITIS IN A TERTIARY CARE CENTRE EPIDEMIOLOGY, CLINICAL PROFILE AND PATCH TEST EVALUATION OCCUPATIONAL CONTACT DERMATITIS IN A TERTIARY CARE CENTRE EPIDEMIOLOGY, CLINICAL PROFILE AND PATCH TEST EVALUATION DONE BY : Dr.Ragini Rajan Final year Post Graduate MD(DVL) Govt.Stanley Medical College,

More information

University of Groningen. P-phenylenediamine Bijkersma-Pot, Laura

University of Groningen. P-phenylenediamine Bijkersma-Pot, Laura University of Groningen P-phenylenediamine Bijkersma-Pot, Laura IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document

More information

Objective To determine the immediate irritation effects and the irritation power of a particular materials.

Objective To determine the immediate irritation effects and the irritation power of a particular materials. SAFETY STUDIES 1.1 Skin Irritation through Open Patch Test 1.2 Skin Irritation through Patch Test. 1.3 Human Skin Irritation Test 1.4 Repeat Open Application Test 1.5 Test For Hypoallergenicity 1.6 Modified

More information

May 24, 2018 OpenTox Asia

May 24, 2018 OpenTox Asia May 24, 2018 OpenTox Asia Development of an artificial neural network model for risk assessment of skin sensitization using multiple in vitro sensitization tests and in silico parameter Morihiko Hirota

More information

EURL ECVAM Strategy for Replacement of Animal Testing for Skin Sensitisation Hazard Identification and Classification

EURL ECVAM Strategy for Replacement of Animal Testing for Skin Sensitisation Hazard Identification and Classification EURL ECVAM Strategy for Replacement of Animal Testing for Skin Sensitisation Hazard Identification and Classification Silvia Casati, Andrew Worth, Patric Amcoff, Maurice Whelan, 2013 Report EUR xxxxx EN

More information

6. Contact allergic reactions in patients with atopic eczema

6. Contact allergic reactions in patients with atopic eczema Acta Derm Venereol 2005; Suppl. 215: 28 32 6. Contact allergic reactions in patients with atopic eczema JOHN MCFADDEN Medicament allergy is a not uncommon problem both with antibiotics and topical corticosteroids.

More information

Commentary Population screening in the NHS: a systematic pathway from evidence to policy formulation

Commentary Population screening in the NHS: a systematic pathway from evidence to policy formulation Journal of Public Health Medicine Vol. 20, No. 1, pp. 58-62 Printed in Great Britain Commentary Population screening in the NHS: a systematic pathway from evidence to policy formulation Robert Sherriff,

More information

Guidelines for implementation of Article 14

Guidelines for implementation of Article 14 Guidelines for implementation of Article 14 Demand reduction measures concerning tobacco dependence and cessation Adopted by the Conference of the Parties at its fourth session (decision FCTC/COP4(8))

More information

Nickel, chromium and cobalt in consumer products: revisiting safe levels in the new millennium

Nickel, chromium and cobalt in consumer products: revisiting safe levels in the new millennium Contact Dermatitis 2003: 49: 1 7 Copyright # Blackwell Munksgaard 2003 Printed in Denmark. All rights reserved CONTACT DERMATITIS ISSN 0105-1873 Review Article Nickel, chromium and cobalt in consumer products:

More information

Alcohol and Drug Commissioning Framework for Northern Ireland Consultation Questionnaire.

Alcohol and Drug Commissioning Framework for Northern Ireland Consultation Questionnaire. Alcohol and Drug Commissioning Framework for Northern Ireland 2013-16 Consultation Questionnaire. This questionnaire has been designed to help stakeholders respond to the above framework. Written responses

More information

AMERICAN COLLEGE OF CLINICAL PHARMACY FELLOW TALLY SHEET AND APPLICANT GUIDE TO SCORING

AMERICAN COLLEGE OF CLINICAL PHARMACY FELLOW TALLY SHEET AND APPLICANT GUIDE TO SCORING AMERICAN COLLEGE OF CLINICAL PHARMACY FELLOW TALLY SHEET AND APPLICANT GUIDE TO SCORING NOMINEE: DATE: REVIEWED BY: SUSTAINED CONTRIBUTION TO ACCP: 1. Min 10 years (Not scored) 4. (Committees) 2. Min 5

More information

Name Title Interests Declared Gifts and Hospitality Dr Andrew Parson

Name Title Interests Declared Gifts and Hospitality Dr Andrew Parson REGISTER OF INTERESTS - BROMLEY CCG GOVERNING BODY JANUARY 2018 ENCLOSURE 1 MEMBERS (STATUTORY) Name Title Interests Declared Gifts and Hospitality Dr Andrew Parson Clinical Chair Chislehurst Medical Practice

More information

The Nutrition and Health Claims Regulation

The Nutrition and Health Claims Regulation , The Nutrition and Health Claims Regulation Dealing with the present Planning for the future THE WORKSHOP In May 2012, after years of negotiation, the European Union (EU) finally adopted its Article 13.1

More information

SAFETY DATA SHEET. PC28: Perfumes, fragrances. PC39: Cosmetics, personal care products.

SAFETY DATA SHEET. PC28: Perfumes, fragrances. PC39: Cosmetics, personal care products. Page: 1 Compilation date: 08/03/2016 Revision date: 19/09/17 Revision No: 3 Section 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name: CAS number:

More information

ImpARAS. Improving Allergy Risk Assessment Strategy for new food proteins. Kitty Verhoeckx, Scientist, TNO, The Netherlands

ImpARAS. Improving Allergy Risk Assessment Strategy for new food proteins. Kitty Verhoeckx, Scientist, TNO, The Netherlands ImpARAS Improving Allergy Risk Assessment Strategy for new food proteins Kitty Verhoeckx, Scientist, TNO, The Netherlands COST Action European network of scientists and researchers and is open to researchers

More information

Safety Evaluation of Cosmetic Ingredients: In Vitro Opportunities for the Identification of Contact Allergens

Safety Evaluation of Cosmetic Ingredients: In Vitro Opportunities for the Identification of Contact Allergens Cosmetics 2014, 1, 61-74; doi:10.3390/cosmetics1010061 Review OPEN ACCESS cosmetics ISSN 2079-9284 www.mdpi.com/journal/cosmetics Safety Evaluation of Cosmetic Ingredients: In Vitro Opportunities for the

More information

Tatiana A. Vogel, Rakita W. Heijnen, Pieter-Jan Coenraads and Marie-Louise A. Schuttelaar

Tatiana A. Vogel, Rakita W. Heijnen, Pieter-Jan Coenraads and Marie-Louise A. Schuttelaar Contact Dermatitis Original Article COD Contact Dermatitis Two decades of p-phenylenediamine and toluene-2,5-diamine patch testing focus on co-sensitizations in the European baseline series and cross-reactions

More information